Skip to main content

Tag Virology

Antivirals, some antibodies, work well against BA.2 omicron variant of COVID-19 virus

March 10, 2022

The research team tested seven monoclonal antibodies, three combinations of antibodies, and three antiviral treatments against the BA.2 variant.

Interview: Keys to a successful COVID-19 vaccine

September 25, 2020

The race to develop a vaccine for the virus that causes COVID-19 will represent the largest global vaccination effort since the fight against polio nearly 70 years ago. That historical perspective is important, says Morgridge Institute virology investigator Paul Ahlquist.

H3N2 viruses mutate during vaccine production but new tech could fix it

April 29, 2019

UW-Madison researchers describe a new cell line that enables better growth of H3N2 for vaccine use. The virus is also far less likely to mutate during production using this cell line, improving the chances of a match between vaccine and circulating influenza viruses.